Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Comment on the contribution by Souayah et al., "Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009".

Slade BA, Gee J, Broder KR, Vellozzi C.

Vaccine. 2011 Jan 29;29(5):865-6. doi: 10.1016/j.vaccine.2010.11.031. Epub 2010 Nov 25. No abstract available.

PMID:
21111783
2.

Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009.

Souayah N, Michas-Martin PA, Nasar A, Krivitskaya N, Yacoub HA, Khan H, Qureshi AI.

Vaccine. 2011 Jan 29;29(5):886-9. doi: 10.1016/j.vaccine.2010.09.020. Epub 2010 Sep 23.

PMID:
20869467
3.

Guillain-Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States.

Ojha RP, Jackson BE, Tota JE, Offutt-Powell TN, Singh KP, Bae S.

Hum Vaccin Immunother. 2014;10(1):232-7. doi: 10.4161/hv.26292. Epub 2013 Sep 6.

4.
5.

Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System.

Souayah N, Nasar A, Suri MF, Qureshi AI.

Vaccine. 2007 Jul 20;25(29):5253-5. Epub 2007 May 22.

PMID:
17560693
6.

Human papillomavirus vaccine safety in pediatric patients: an evaluation of the Vaccine Adverse Event Reporting System.

Borja-Hart NL, Benavides S, Christensen C.

Ann Pharmacother. 2009 Feb;43(2):356-9. doi: 10.1345/aph.1L492. Epub 2009 Jan 20.

PMID:
19155346
7.

Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance.

Gold MS, McIntyre P.

Sex Health. 2010 Sep;7(3):320-4. doi: 10.1071/SH09153.

PMID:
20719221
8.

Letter to the Editor. Guillain-Barré Syndrome(GBS) after vaccination reported to the United States Vaccine Adverse Event Reporting System(VAERS) in 2004.

Haber P, Slade B, Iskander J.

Vaccine. 2007 Nov 23;25(48):8101. Epub 2007 Oct 1. No abstract available.

PMID:
17933441
9.

Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, October 2005-February 2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2006 Apr 7;55(13):364-6.

10.

Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.

Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P.

Vaccine. 2009 Mar 26;27(15):2114-20. doi: 10.1016/j.vaccine.2009.01.125. Epub 2009 Feb 6.

PMID:
19356614
11.

Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.

Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, Cano M, Lewis P, McNeil MM, Bryant M, Singleton J, Martin D, DeStefano F.

Vaccine. 2010 Oct 21;28(45):7248-55. doi: 10.1016/j.vaccine.2010.09.021. Epub 2010 Sep 16.

PMID:
20850534
12.

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, Clark S, Haber P, Stolley PD, Schonberger LB, Chen RT.

N Engl J Med. 1998 Dec 17;339(25):1797-802.

13.
14.

A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study.

Velentgas P, Bohn RL, Brown JS, Chan KA, Gladowski P, Holick CN, Kramer JM, Nakasato C, Spettell CM, Walker AM, Zhang F, Platt R.

Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1226-34. doi: 10.1002/pds.1675.

PMID:
18956428
15.

Quadrivalent HPV vaccination reactions--more hype than harm.

Douglas RJ.

Aust Fam Physician. 2009 Mar;38(3):139-42.

16.

[Vaccination against influenza and Guillain-Barre syndrome: are there any relations?].

Wiercińska-Drapało A, Grzeszczuk A, Wasilewski K, Prokopowicz D.

Pol Merkur Lekarski. 2000 May;8(47):360-1. Review. Polish.

PMID:
10944963
17.
18.

Guillain-Barre syndrome after influenza vaccine administration: two adult cases.

Bedard Marrero V, Osorio Figueroa RL, Vázquez Torres O.

Bol Asoc Med P R. 2010 Apr-Jun;102(2):39-41.

PMID:
20939203
19.

[Guillain-Barré syndrome and anti-hepatitis A vaccination].

Roux X, Gramond C, De Greslan T, Sallansonnet-Froment M, Aoun O, Ouologuem M, Taillia H, Renard JL.

Med Mal Infect. 2010 Aug;40(8):490-2. doi: 10.1016/j.medmal.2009.10.003. Epub 2009 Nov 28. French.

PMID:
19945808
20.

An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink.

Yih WK, Nordin JD, Kulldorff M, Lewis E, Lieu TA, Shi P, Weintraub ES.

Vaccine. 2009 Jul 9;27(32):4257-62. doi: 10.1016/j.vaccine.2009.05.036. Epub 2009 May 30.

PMID:
19486957
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk